NCT05577169 is a NA clinical trial of Mind-body skills in Type 1 Diabetes, sponsored by Indiana University.

Who is sponsoring NCT05577169?

NCT05577169 is sponsored by Indiana University.

What drugs are being tested in NCT05577169?

Interventions in NCT05577169: Mind-body skills, Diabetes education.

What condition does NCT05577169 study?

NCT05577169 studies Type 1 Diabetes, Adolescent Behavior.

Is NCT05577169 still recruiting?

NCT05577169 is currently completed. Last updated 7 April 2025.

Last reviewed 2025-04-07 · How we verify

NCT05577169

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes

Completed NA Last updated 7 April 2025

What this trial tests

NA trial testing Mind-body skills in Type 1 Diabetes in 30 participants. Completed in 31 December 2024.

Timeline

14 September 2022

Primary endpoint
30 June 2024

31 December 2024

Quick facts

Lead sponsor	Indiana University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	14 September 2022
Primary completion	30 June 2024
Estimated completion	31 December 2024
Sites	2 locations across United States

Drugs / interventions tested

Mind-body skills
Diabetes education

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →
Adolescent Behavior — all drugs for Adolescent Behavior →

Sponsor

Indiana University

Who can join

Adults 15 to 17, any sex, with Type 1 Diabetes or Adolescent Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compliance in this age group, none have been deemed superior. The purpose of this study is to incorporate mindfulness skills in with diabetes education sessions for adolescents with type 1 diabetes and study if this translates to improved outcomes in glycemic control, patient satisfaction, and mental wellness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Indiana University trials

Trials by the same sponsor.

NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05577169 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indiana University
Last refreshed: 7 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05577169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing